CHRISTIAN THOMPSON: Open Payments
NPI 1245796366 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 33 payments from 13 companies in 2025. Trend: 2023 $251 · 2024 $750 · 2025 $1,010
Food & beverage: $842Education: $168
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $241 |
| GENZYME CORPORATION | 4 | $196 |
| Janssen Biotech, Inc. | 3 | $126 |
| Incyte Corporation | 2 | $104 |
| Arcutis Biotherapeutics, Inc. | 5 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| Amgen Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $29 |
| UCB, Inc. | 1 | $28 |
Products named: DUPIXENT, TREMFYA, Opzelura, Zoryve, SPEVIGO, OTEZLA, TALTZ, Bimzelx.
Industry payments across CA — which companies pay providers there.
